A Nashville doctor helped pioneer an FDA approved "state-of-the-art" gene-editing therapy that could be a cure for painful ...
Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these ...
Morning Overview on MSN
The FDA approved the first gene therapy for sickle cell in children as young as two
Regulators have opened a one-time gene therapy to some of the youngest patients with sickle cell disease. On July 1, 2026, ...
Sickle cell is a genetic blood condition that can cause severe pain, extreme tiredness and serious health complications. It mainly affects people of African and Caribbean heritage, and for many, it's ...
The first person to ever be cured of sickle cell anemia in Louisiana received revolutionary gene therapy. The treatment is ...
Gene therapy has changed what is possible for people living with sickle cell disease. New treatments have shown that the ...
7d
Agios Pharmaceuticals Shares Rise After FDA Grants Priority Review for Sickle Cell Disease Treatment
Agios Pharmaceuticals shares rose Tuesday after the U.S. Food and Drug Administration granted priority review to the company's supplemental new drug application for mitapivat to treat sickle cell ...
Research has found a strong correlation between painful periods and high rates of depression, anxiety and suicidal thoughts ...
By Yiqing Wang/WHRO State lawmakers have budgeted nearly $15 million over two years to help Virginia Medicaid cover gene ...
Sickle cell disease (SCD) can affect people of any ethnicity but is much more common among Africans and African Americans. Other ethnic groups with higher rates of SCD include Hispanic Americans from ...
Muhammadu Sanusi II, Emir of Kano, has renewed the Kano Emirate's campaign against sickle cell disease, urging greater public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results